Overall survival and progression-free survival in patients with primary brain tumors after treatment: is the outcome of [18F] FDOPA PET a prognostic factor in these patients?

World Medical Association Declaration of Helsinki

JAMA · 2013 · 29.4K citations

Health Professions, Health Sciences, Clinical Medicine +2

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

Patrick Y. Wen, David R. Macdonald, David A. Reardon et al. · Journal of Clinical Oncology · 2010 · 3.8K citations · Full text

Medicine, Neurology, Oncology +15

Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)

Riccardo Soffietti, Ufuk Abacıoğlu, Brigitta G. Baumert et al. · Neuro-Oncology · 2016 · 503 citations · Full text

Medicine, Oncology, Surgery +17

Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma

Kaisorn L. Chaichana, Ignacio Jusué-Torres, Rodrigo Navarro-Ramírez et al. · Neuro-Oncology · 2013 · 494 citations · Full text

Medicine, Oncology, Surgery +16

Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype

Benjamin Alderete, Yuriko Minn, Thomas J. Borell et al. · Oncogene · 1999 · 376 citations

Medicine, Molecular Genetics, Oncology +16